臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 571-595 / 1656 (共67頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-02-02T00:46:53Z	Systemic therapy for metastatic urothelial carcinoma	Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU; Vogelzang N.J.
臺大學術典藏	2021-02-02T00:46:51Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Lin C.-C.; YEONG-SHIAU PU; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H.
臺大學術典藏	2021-02-02T00:46:47Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏	2021-02-02T00:46:29Z	Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells	Huang K.-H.; Kuo K.-L.; Ho I.-L.; Chang H.-C.; Chuang Y.-T.; Lin W.-C.; Lee P.-Y.; Chang S.-C.; Chiang C.-K.; YEONG-SHIAU PU; Chou C.-T.; Hsu C.-H.; Liu S.-H.
臺大學術典藏	2021-02-02T00:46:21Z	MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies	Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Chang H.-C.;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Yeong-Shiau Pu;Huang K.-H.; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU; Huang K.-H.
臺大學術典藏	2021-02-02T00:46:17Z	MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma	Ho I.-L.;Kuo K.-L.;Liu S.-H.-.;Chang H.-C.;Hsieh J.-T.;Wu J.-T.;Chiang C.-K.;Lin W.-C.;Tsai Y.-C.;Chou C.-T.;Hsu C.-H.;Yeong-Shiau Pu;Shi C.-S.;Huang K.-H.; Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; YEONG-SHIAU PU; Shi C.-S.; Huang K.-H.
臺大學術典藏	2021-02-02T00:46:08Z	A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement	Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Yeong-Shiau Pu; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏	2021-01-28T03:15:20Z	Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study	Shi C.-S.;Kuo K.-L.;Chen M.-S.;Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Huang K.-H.; Shi C.-S.; Kuo K.-L.; Chen M.-S.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; Huang K.-H.
臺大學術典藏	2021-01-28T03:15:20Z	The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study	Kuo K.-L.;Liu S.-H.;Lin W.-C.;Po-Ming Chow;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; PO-MING CHOW; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H.
臺大學術典藏	2021-01-28T02:03:54Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2021-01-28T02:03:54Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2021-01-28T02:03:53Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Kuo-How Huang;Chen J.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; KUO-HOW HUANG; Chen J.; Pu Y.-S.
臺大學術典藏	2021-01-28T02:03:44Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2021-01-28T02:03:27Z	Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells	Kuo-How Huang;Kuo K.-L.;Ho I.-L.;Chang H.-C.;Chuang Y.-T.;Lin W.-C.;Lee P.-Y.;Chang S.-C.;Chiang C.-K.;Pu Y.-S.;Chou C.-T.;Hsu C.-H.;Liu S.-H.; KUO-HOW HUANG; Kuo K.-L.; Ho I.-L.; Chang H.-C.; Chuang Y.-T.; Lin W.-C.; Lee P.-Y.; Chang S.-C.; Chiang C.-K.; Pu Y.-S.; Chou C.-T.; Hsu C.-H.; Liu S.-H.
臺大學術典藏	2021-01-28T02:03:22Z	MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies	Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Chang H.-C.;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Pu Y.-S.;Kuo-How Huang; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:03:18Z	MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma	Ho I.-L.;Kuo K.-L.;Liu S.-H.-.;Chang H.-C.;Hsieh J.-T.;Wu J.-T.;Chiang C.-K.;Lin W.-C.;Tsai Y.-C.;Chou C.-T.;Hsu C.-H.;Pu Y.-S.;Shi C.-S.;Kuo-How Huang; Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:58Z	Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study	Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:45Z	Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study	Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:44Z	The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study	Kuo K.-L.;Liu S.-H.;Lin W.-C.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T02:02:43Z	Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study	Shi C.-S.;Kuo K.-L.;Chen M.-S.;Chow P.-M.;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Kuo-How Huang; Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; KUO-HOW HUANG
臺大學術典藏	2021-01-28T01:07:01Z	Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers	Hsu C.-H.;Kun-Huei Yeh;Chen L.-T.;Liu J.M.;Jan C.-M.;Lin J.-T.;Chen Y.-C.;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; Chen Y.-C.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:07:00Z	Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin	Hsu C.-H.;Kun-Huei Yeh;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏	2021-01-28T01:07:00Z	A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers	Kun-Huei Yeh;Cheng A.-L.;Lin M.-T.;Hong R.-L.;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Lee P.-H.;Chen Y.-C.; KUN-HUEI YEH; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C.
臺大學術典藏	2021-01-28T01:06:55Z	Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil	Hsu C.-H.;Kun-Huei Yeh;Lui L.T.;Lee Y.-C.;Bu C.-F.;Wang H.-P.;Lin J.-T.;Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Lui L.T.; Lee Y.-C.; Bu C.-F.; Wang H.-P.; Lin J.-T.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:54Z	Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil	Kun-Huei Yeh;Yeh S.-H.;Hsu C.-H.;Wang T.-M.;Ma I.-F.;Cheng A.-L.; KUN-HUEI YEH; Yeh S.-H.; Hsu C.-H.; Wang T.-M.; Ma I.-F.; Cheng A.-L.

顯示項目 571-595 / 1656 (共67頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52728297 線上人數 : 547 教育部委託研究計畫計畫執行:國立臺灣大學圖書館